By year-end, we are happy to report that we had 107 partners who are running 407 active programs. As our partner pipeline ...

Ovid Therapeutics advances OV329, a GABA-AT inhibitor, into Phase 2 for drug-resistant adult focal onset seizures post ...

Spyre Therapeutics, Inc. earns a Strong Buy on Phase 1 wins, IBD/RA pipeline catalysts, and $757M cash runway. Click for this ...

At Empa, an interdisciplinary research institute for materials science and technology within the ETH Domain, researchers are ...

This article explores how advanced immune imaging technologies enable real-time visualization of immune responses, improving ...

As dangerous microbes grow harder to control, researchers are exploring new ways to neutralise them using light-activated ...

Financial services opportunities do not always come along — sometimes you have to go looking for them and be ready to make ...

In State of City address, Mayor Mike Rosen says Edmonds is delivering “big‑city services” with lean staffing and tight ...

KORU Medical Systems, Inc. (NASDAQ:KRMD) Q4 2025 Earnings Call Transcript March 12, 2026 KORU Medical Systems, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.02.

Three years ago, the Writers Guild of America went on a 148-day strike to fight what it called an "existential threat" to the ...

Nothing captures the imagination of football fans quite like the FIFA World Cup, a tournament where drama unfolds on the ...

Liquid biopsies are expanding: Blood tests that can detect cancer are moving beyond just late-stage treatment selection. They ...